butenolide has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, M; Qi, C; Qiao, Y; Shi, Z; Sun, W; Tao, L; Xie, S; Zhang, Y | 1 |
| Chen, C; Gao, W; Guan, D; Hu, Z; Lai, Y; Liu, M; Qi, C; Wang, J; Zhang, Y; Zhou, Q; Zhou, Y; Zhu, H | 1 |
| Ito, M; Iwashima, A; Nishino, H; Satomi, Y; Tamai, Y; Torihara, M | 1 |
3 other study(ies) available for butenolide and Pancreatic Neoplasms
| Article | Year |
|---|---|
New cytotoxic secondary metabolites against human pancreatic cancer cells from the Hypericum perforatum endophytic fungus Aspergillus terreus.
Topics: 4-Butyrolactone; Antineoplastic Agents; Aspergillus; Cell Line, Tumor; China; Flowers; Humans; Hypericum; Lovastatin; Pancreatic Neoplasms | 2020 |
Butenolides from a marine-derived fungus Aspergillus terreus with antitumor activities against pancreatic ductal adenocarcinoma cells.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Aspergillus; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pancreatic Neoplasms; Structure-Activity Relationship | 2018 |
Inhibitory effects of (1E,3E,5E,7E)-5-hydroxy-4-(8-phenyl-1,3,5,7- octatetraenyl)-2(5H)-furanone on proliferation of human malignant tumor cells.
Topics: 4-Butyrolactone; Antineoplastic Agents; Blotting, Northern; Carotenoids; Cell Division; DNA, Neoplasm; Flow Cytometry; Furans; Genes, myc; HeLa Cells; Humans; Neoplasm Proteins; Neuroblastoma; Pancreatic Neoplasms; RNA, Messenger; Stomach Neoplasms; Thymidine; Tumor Cells, Cultured | 1992 |